List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 41 studies with search of: "Gout"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Long Term Study of Canakinumab (ACZ885) in Patients With Gout
Condition: Gout
Intervention: Drug: Canakinumab
2 Completed Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout
Condition: Gout
Intervention: Biological: Pegloticase
3 Active, not recruiting Evaluating Efficacy of Canakinumab (ACZ885) in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy
Condition: Gout
Interventions: Drug: ACZ885;   Drug: Colchicine
4 Recruiting Review of Safety Using Rilonacept in Preventing Gout Exacerbations (RE-SURGE)
Condition: Gout
Interventions: Biological: Rilonacept;   Other: Placebo
5 Recruiting PREventative Study Against URate-Lowering Drug-Induced Gout Exacerbations (PRE-SURGE 2)
Condition: Gout
Interventions: Drug: placebo;   Drug: rilonacept
6 Recruiting Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout
Condition: Gout
Interventions: Drug: placebo;   Drug: BCX4208
7 Completed A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
Condition: Gout
Intervention: Drug: Puricase
8 Active, not recruiting Re-Exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
Condition: Treatment Failure Gout
Intervention: Drug: pegloticase 8 mg i.v.
9 Completed
Has Results 		Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
Condition: Gout
Interventions: Drug: Febuxostat;   Drug: Allopurinol;   Drug: Placebo
10 Active, not recruiting PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
Condition: Intercritical Gout
Intervention: Drug: rilonacept
11 Completed Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients
Condition: Acute Gout
Interventions: Drug: ACZ885;   Drug: Triamcinolone acetonide
12 Recruiting Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use Non-steroidal Anti-inflammatory Drugs (NSAIDs) and/or Colchicine
Condition: Acute Gout
Interventions: Drug: ACZ885;   Drug: Triamcinolone acetonide
13 Recruiting Study Utilizing Rilonacept in Gout Exacerbations
Condition: Acute Gout Flare
Interventions: Drug: placebo and indomethacin;   Drug: rilonacept and indomethacin;   Drug: rilonacept and placebo
14 Completed
Has Results 		Febuxostat Versus Allopurinol Control Trial in Subjects With Gout
Condition: Gout
Interventions: Drug: Febuxostat;   Drug: Allopurinol
15 Completed Safety and Efficacy Study of PEG-Uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout
Condition: Gout
Interventions: Other: placebo;   Biological: pegloticase
16 Completed
Has Results 		Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout
Condition: Gout
Interventions: Drug: Placebo;   Drug: Febuxostat
17 Completed
Has Results 		Efficacy and Safety of Oral Febuxostat in Subjects With Gout
Condition: Gout
Interventions: Drug: Febuxostat;   Drug: Allopurinol
18 Completed
Has Results 		Long-Term Safety of Febuxostat in Subjects With Gout.
Condition: Gout
Intervention: Drug: Febuxostat
19 Completed Phase III Trial of Febuxostat in Korea Gout Patients
Condition: Gout
Intervention: Drug: Febuxostat
20 Completed Study of the Safety and Effectiveness of Rilonacept for the Prevention of Gout Flares
Condition: Gout
Interventions: Biological: rilonacept;   Other: placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services